中文 | English
Return
Total: 5 , 1/1
Show Home Prev Next End page: GO
Author:( Kosuke Sakamoto)

1.Therapeutic Impact on Quality of Life in Adult Patients With Chronic Intestinal Pseudo-obstruction: A Multicenter, Cohort Study

Kota TAKAHASHI ; Takaomi KESSOKU ; Hidenori OHKUBO ; Yo ISHIHARA ; Kosuke TANAKA ; Tomoki OGATA ; Tsumugi JONO ; Atsushi YAMAMOTO ; Anna OZAKI ; Yuki KASAI ; Michihiro IWAKI ; Akiko FUYUKI ; Takayuki KATO ; Yasunari SAKAMOTO ; Takeo KURIHASHI ; Hirotoshi EBINUMA ; Atsushi NAKAJIMA

Journal of Neurogastroenterology and Motility 2026;32(2):244-253

2.Effectiveness of Endoscopic Sclerotherapy with Aluminum Potassium Sulfate and Tannic Acid as a Non-Surgical Treatment for Internal Hemorrhoids

Yuichi TOMIKI ; Jun AOKI ; Shunsuke MOTEGI ; Rina TAKAHASHI ; Toshiaki HAGIWARA ; Yu OKAZAWA ; Kosuke MIZUKOSHI ; Masaya KAWAI ; Shinya MUNAKATA ; Shun ISHIYAMA ; Kiichi SUGIMOTO ; Kazuhiro SAKAMOTO

Clinical Endoscopy 2019;52(6):581-587

3.Multiple Infected Aneurysms of the Aortic Arch and Thoraco-abdominal Aorta Caused by Bacteroides fragilis

Yoichi Yamashita ; Sayako Nakagawa ; Kosuke Sakamoto ; Taiko Horii

Japanese Journal of Cardiovascular Surgery 2015;44(4):188-192

4.Usefulness of the Endotoxin Activity Assay to Evaluate the Degree of Lung Injury.

Yuichiro SAKAMOTO ; Satoshi INOUE ; Takashi IWAMURA ; Tomoko YAMASHITA ; Atsushi NAKASHIMA ; Hiroyuki KOAMI ; Toru MIIKE ; Mayuko YAHATA ; Hisashi IMAHASE ; Akiko GOTO ; Showgo NARUMI ; Miho OHTA ; Chris Kosuke YAMADA

Yonsei Medical Journal 2014;55(4):975-979

5.Studies on Therapeutic Effects and Pathological Features of an Antithrombin Preparation in Septic Disseminated Intravascular Coagulation Patients.

Yuichiro SAKAMOTO ; Satoshi INOUE ; Takashi IWAMURA ; Tomoko YAMASHITA ; Atsushi NAKASHIMA ; Yoichi NISHIMURA ; Hiroyuki KOAMI ; Hisashi IMAHASE ; Akiko GOTO ; Kosuke Chris YAMADA ; Kunihiro MASHIKO ; Hiroyuki YOKOTA

Yonsei Medical Journal 2013;54(3):686-689

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 5 , 1/1 Show Home Prev Next End page: GO